Condition: Trichomonas Vaginitis · Bacterial Vaginitis · Sponsor: Tulane University
This is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
This description comes directly from the study's public registry record.
Patricia Kissinger, PhD · 504-988-7320 · kissing@tulune.edu
Christina Muzny, MD · 205-975-3298 · cmuzny@uabmc.edu
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham [UAB] Gynecology Clinics | Birmingham, Alabama, United States | Recruiting |
| UAB Sexual Health Research Clinic [SHRC] | Birmingham, Alabama, United States | Recruiting |
| Segal Trials Healthcare Clinical Data, Inc. 1065 NE 125th St. Suite 417 North Miami, FL 33161 | North Miami, Florida, United States | Not Yet Recruiting |
| LSU-CrescentCare Sexual Health Center | New Orleans, Louisiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06261840